Table of Contents
PHARMACEUTICAL MANUFACTURING: NEW TECHNOLOGY OPPORTUNITIES.. G.K.Raju, Ph.D. Executive Director, Pharmaceutical Manufacturing Initiative (PHARMI), MIT Program on the Pharmaceutical Industry, Massachusetts Institute of Technology
OUTLINE
PPT Slide
PPT Slide
PPT Slide
PPT Slide
OUTLINE
PPT Slide
PPT Slide
PPT Slide
PPT Slide
OUTLINE
PROCESS D: BLENDING PROCESS DEVELOPMENT
PPT Slide
PPT Slide
PPT Slide
OUTLINE
PPT Slide
PROCESS A WITH QC TESTS
PROCESS A WITH CYCLE TIMES
PROCESS D WITH QC TESTS
PROCESS D WITH CYCLE TIMES
PROCESS D WITH QC TESTS: Cycle Times including BULK ACTIVE
PPT Slide
PROCESS E WITH QC TEST TIMES
PPT Slide
PROCESS F: LIQUID LINE WITH CYCLE TIMES
OVERALL CYCLE TIMES: QC TESTING TIMES ARE SIGNIFICANT
CYCLE TIME COMPONENTS
ON-LINE TECHNOLOGY IMPACTS DOMINANT CYCLE TIMES
WHAT DRIVES THE QC TESTING TIMES?
PPT Slide
OUTLINE
PPT Slide
PHARMACEUTICAL MANUFACTURING: LOOKING BEYOND THE “AVERAGE”
OUTLINE
OVERALL CYCLE TIMES: QC TESTING TIMES ARE SIGNIFICANT
Pharmaceutical Manufacturing: Impact of Exceptions
OUTLINE
PPT Slide
PPT Slide
PHARMACEUTICAL MANUFACTURING: The New Technology Opportunity..
PPT Slide
ACKNOWLEDGEMENTS
NOTE ON CONTEXT
|